A detailed history of King Luther Capital Management Corp transactions in Zoetis Inc. stock. As of the latest transaction made, King Luther Capital Management Corp holds 1,815,949 shares of ZTS stock, worth $299 Million. This represents 1.54% of its overall portfolio holdings.

Number of Shares
1,815,949
Previous 1,789,031 1.5%
Holding current value
$299 Million
Previous $310 Million 14.4%
% of portfolio
1.54%
Previous 1.41%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$172.58 - $196.48 $4.65 Million - $5.29 Million
26,918 Added 1.5%
1,815,949 $355 Million
Q2 2024

Aug 12, 2024

SELL
$145.54 - $178.83 $5.29 Million - $6.5 Million
-36,366 Reduced 1.99%
1,789,031 $310 Million
Q1 2024

May 13, 2024

SELL
$165.67 - $199.94 $15.9 Million - $19.2 Million
-95,835 Reduced 4.99%
1,825,397 $309 Million
Q4 2023

Feb 09, 2024

BUY
$151.44 - $200.09 $1.19 Million - $1.57 Million
7,846 Added 0.41%
1,921,232 $379 Million
Q3 2023

Nov 13, 2023

SELL
$167.14 - $192.77 $858,431 - $990,066
-5,136 Reduced 0.27%
1,913,386 $333 Million
Q2 2023

Aug 10, 2023

BUY
$160.94 - $186.23 $762,372 - $882,171
4,737 Added 0.25%
1,918,522 $330 Million
Q1 2023

May 11, 2023

BUY
$145.48 - $175.02 $278,739 - $335,338
1,916 Added 0.1%
1,913,785 $319 Million
Q4 2022

Feb 13, 2023

SELL
$131.14 - $157.47 $1.62 Million - $1.94 Million
-12,342 Reduced 0.64%
1,911,869 $280 Million
Q3 2022

Nov 10, 2022

SELL
$148.29 - $182.55 $488,912 - $601,867
-3,297 Reduced 0.17%
1,924,211 $285 Million
Q2 2022

Aug 11, 2022

SELL
$155.97 - $200.09 $1.7 Million - $2.18 Million
-10,901 Reduced 0.56%
1,927,508 $331 Million
Q1 2022

May 11, 2022

BUY
$181.39 - $234.03 $354,436 - $457,294
1,954 Added 0.1%
1,938,409 $366 Million
Q4 2021

Feb 14, 2022

SELL
$193.69 - $247.03 $3.5 Million - $4.46 Million
-18,053 Reduced 0.92%
1,936,455 $473 Million
Q3 2021

Nov 10, 2021

SELL
$189.29 - $209.69 $4.14 Million - $4.58 Million
-21,851 Reduced 1.11%
1,954,508 $379 Million
Q2 2021

Aug 13, 2021

SELL
$155.9 - $187.99 $1.22 Million - $1.47 Million
-7,809 Reduced 0.39%
1,976,359 $368 Million
Q1 2021

May 12, 2021

BUY
$144.0 - $169.39 $2.58 Million - $3.04 Million
17,921 Added 0.91%
1,984,168 $312 Million
Q4 2020

Feb 10, 2021

BUY
$157.07 - $174.35 $312,255 - $346,607
1,988 Added 0.1%
1,966,247 $325 Million
Q3 2020

Nov 12, 2020

SELL
$137.1 - $165.37 $1.74 Million - $2.09 Million
-12,667 Reduced 0.64%
1,964,259 $325 Million
Q2 2020

Aug 12, 2020

BUY
$111.92 - $142.53 $614,664 - $782,774
5,492 Added 0.28%
1,976,926 $271 Million
Q1 2020

May 13, 2020

SELL
$92.66 - $144.94 $2.61 Million - $4.08 Million
-28,127 Reduced 1.41%
1,971,434 $232 Million
Q4 2019

Feb 12, 2020

BUY
$116.25 - $133.25 $1.91 Million - $2.18 Million
16,388 Added 0.83%
1,999,561 $265 Million
Q3 2019

Nov 12, 2019

BUY
$112.57 - $128.43 $2.42 Million - $2.76 Million
21,527 Added 1.1%
1,983,173 $247 Million
Q2 2019

Aug 12, 2019

BUY
$97.98 - $114.28 $4.42 Million - $5.16 Million
45,141 Added 2.36%
1,961,646 $223 Million
Q1 2019

May 10, 2019

BUY
$81.56 - $100.67 $2.71 Million - $3.34 Million
33,177 Added 1.76%
1,916,505 $193 Million
Q4 2018

Feb 12, 2019

BUY
$79.28 - $95.27 $1.48 Million - $1.78 Million
18,693 Added 1.0%
1,883,328 $161 Million
Q3 2018

Nov 13, 2018

BUY
$83.5 - $93.23 $3.33 Million - $3.72 Million
39,877 Added 2.19%
1,864,635 $171 Million
Q2 2018

Aug 13, 2018

BUY
$79.9 - $89.2 $21.7 Million - $24.2 Million
271,781 Added 17.5%
1,824,758 $155 Million
Q1 2018

May 08, 2018

BUY
$71.51 - $84.69 $17.9 Million - $21.2 Million
250,913 Added 19.27%
1,552,977 $130 Million
Q4 2017

Feb 12, 2018

BUY
$63.24 - $72.8 $2.4 Million - $2.76 Million
37,900 Added 3.0%
1,302,064 $93.8 Million
Q3 2017

Nov 13, 2017

BUY
$59.73 - $65.4 $75.5 Million - $82.7 Million
1,264,164
1,264,164 $80.6 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.2B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track King Luther Capital Management Corp Portfolio

Follow King Luther Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on King Luther Capital Management Corp with notifications on news.